Editorial

MS Has Learnt to Stop Inflammation. It Still Cannot Repair the Damage.

A Boot-Camp Flu Outbreak Put Pentagon Vaccine Policy to the Test.

England Moved the Vaccine Clock. The Coverage Gap Stayed Put

Resistant hypertension may need a diagnostic revolution, not just another drug

When diabetes tech fails, personalised care fails with it

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.

MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.

For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
